The Largest Security-Cleared Career Network for Defense and Intelligence Jobs - JOIN NOW

Homeland Security

Global Times

Shanghai hospital nurse confirmed as COVID-19 patient, with one community designated as medium-risk area

Global Times

By Global Times Published: Aug 18, 2021 08:33 PM

A nurse from Shanghai Songjiang District Central Hospital was confirmed as having COVID-19 on Wednesday and has been transferred to Shanghai Public Health Clinical Center for quarantine and treatment, the Shanghai Municipal Health Commission announced on Wednesday evening.

The nurse had not been to other provinces over the past two weeks or had any contact with other domestic epidemic-hit areas recently.

According to the local health authority, the patient has had two vaccine doses and before she was tested positive for COVID-19 on Wednesday she tested negative in all the nucleic acid tests she took once every three days since August 2.

Epidemiological investigations show that she had not left Shanghai over the past 14 days.

The hospital where she works suspended its outpatient and emergency services on Wednesday and has been conducting nucleic acid tests among all related personnel.

All the places the nurse visited over the past two weeks have been placed under closed management and have been disinfected.

She had been to the Eye & ENT Hospital of Fudan University, which has also suspended its outpatient and emergency services on Wednesday to carry out nucleic acid testing.

As of 6 pm, 10 close contacts of the patient have been placed under quarantine and they all tested negative for the virus during the first round of nucleic acid testing.

Sixty-six close contacts of the 10 people and another 7,347 related personnel all tested negative. A total of 272 samples collected from the environment related to the patient all tested negative.

The Youlu Apartment residential compound in Yongfeng community, Songjiang district where the nurse lives has been designated as a medium-risk area while the rest of Shanghai remains low-risk.

Join the mailing list